C5 inhibitors are not C5a inhibitors

被引：0
|
作者：
Lim, Endry H. T. [1 ,2 ,3 ]
Vlaar, Alexander P. J. [1 ]
de Bruin, Sanne [1 ]
Brouwer, Matthijs C. [2 ]
van de Beek, Diederik [2 ]
机构：
[1] Amsterdam UMC locat Univ Amsterdam, Dept Intens Care Med, Amsterdam, Netherlands
[2] Amsterdam UMC locat Univ Amsterdam, Dept Neurol, Amsterdam, Netherlands
[3] Amsterdam UMC, Dept Intens Care Med, Locat AMC, Room C3-421,Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands
来源：
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY | 2023年 / 21卷 / 06期
关键词：
D O I：
10.1080/14787210.2023.2197211
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：685 / 686
页数：2
相关论文
共 50 条
  • [1] Recent developments in C5/C5a inhibitors
    Proctor, LM
    Woodruff, TM
    Taylor, SM
    [J]. EXPERT OPINION ON THERAPEUTIC PATENTS, 2006, 16 (04) : 445 - 458
  • [2] Development of an Automated Complement C5 Functional Assay for Personalized Monitoring of Patients on C5 Inhibitors
    Martins, Thomas
    Wilcox, Tanya
    Muhlestein, Desirae
    Elgort, Marc
    Delgado, Julio
    Nandakumar, Vijayalakshmi
    [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2022, 158 (SUPP 1) : S11 - S12
  • [3] Derivation of RNA aptamer inhibitors of human C5
    Biesecker, G
    Dihel, L
    Enney, K
    Bendele, R
    [J]. MOLECULAR IMMUNOLOGY, 1998, 35 (6-7) : 334 - 334
  • [4] Application of C5 inhibitors in glomerular diseases in 2021
    Werion, Alexis
    Rondeau, Eric
    [J]. KIDNEY RESEARCH AND CLINICAL PRACTICE, 2022, 41 (04) : 412 - 421
  • [5] HUMAN C5 ANAPHYLATOXIN (C5A) - PARTIAL CHEMICAL CHARACTERIZATION
    FERNANDEZ, HN
    HUGLI, TE
    [J]. FEDERATION PROCEEDINGS, 1976, 35 (07) : 1762 - 1762
  • [6] Inhibitors of C5 complement enhance vaccinia virus oncolysis
    D Magge
    Z S Guo
    M E O'Malley
    L Francis
    R Ravindranathan
    D L Bartlett
    [J]. Cancer Gene Therapy, 2013, 20 : 342 - 350
  • [7] Inhibitors of C5 complement enhance vaccinia virus oncolysis
    Magge, D.
    Guo, Z. S.
    O'Malley, M. E.
    Francis, L.
    Ravindranathan, R.
    Bartlett, D. L.
    [J]. CANCER GENE THERAPY, 2013, 20 (06) : 342 - 350
  • [8] Derivation of RNA aptamer inhibitors of human complement C5
    Biesecker, G
    Dihel, L
    Enney, K
    Bendele, RA
    [J]. IMMUNOPHARMACOLOGY, 1999, 42 (1-3): : 219 - 230
  • [9] C5 deficiency and C5a or C5aR blockade protects against cerebral malaria
    Patel, Samir N.
    Berghout, Joanne
    Lovegrove, Fiona E.
    Ayi, Kodjo
    Conroy, Andrea
    Serghides, Lena
    Min-oo, Gundula
    Gowda, D. Channe
    Sarma, J. Vidya
    Rittirsch, Daniel
    Ward, Peter A.
    Liles, W. Conrad
    Gros, Philippe
    Kain, Kevin C.
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2008, 205 (05): : 1133 - 1143
  • [10] Possible involvement of C5/C5a in the efferent and elicitation phase of contact sensitivity
    Tsuji, RF
    Kikuchi, M
    Askenase, PW
    [J]. JOURNAL OF IMMUNOLOGY, 1996, 156 (12): : 4644 - 4650
12345